Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Lenalidomide promotes the development of TP53 -mutated therapy-related myeloid neoplasms

Blood (2022) 140 (16): 1753–1763.

https://doi.org/10.1182/blood.2021014956

Published: 2022

Includes: Supplemental data

Journal Articles

Clonal dynamics and clinical implications of postremission clonal hematopoiesis in acute myeloid leukemia

Blood (2021) 138 (18): 1733–1739.

https://doi.org/10.1182/blood.2020010483

Published: 2021

Includes: Supplemental data

Journal Articles

Prognostic Significance of Genetic Alterations in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Hyper-CVAD Plus Dasatinib or Hyper-CVAD Plus Ponatinib

Yuya Sasaki, MDPhD, Hagop M. Kantarjian, MD, Nicholas J. Short, MD, Nitin Jain, MD, Koji Sasaki, MD, Farhad Ravandi, MBBS, Marina Konopleva, MD PhD, Guillermo Garcia-Manero, MD, Latasha Little, BS, Curtis Gumbs, Li Zhao, PhD, P Andrew Futreal, PhD, Feng Wang, PhD, Ken Furudate, DDM, PhD, Rebecca Garris, MSc, Koichi Takahashi, MD PhD, Elias Jabbour, MD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-136676

Published: 2020

Journal Articles

Clonal Dynamics and Clinical Implications of Post-Remission Clonal Hematopoiesis in Acute Myeloid Leukemia (AML)

Tomoyuki Tanaka, Kiyomi Morita, MD, Feng Wang, PhD, Latasha Little, Curtis Gumbs, Jairo Matthews, Courtney D. DiNardo, MDMSc, Tapan M. Kadia, MD, Farhad Ravandi, MD, Marina Y Konopleva, MD PhD, Hagop M. Kantarjian, MD, Richard E. Champlin, MD, Guillermo Garcia-Manero, MD, P Andrew Futreal, PhD, Koichi Takahashi, MD

Blood (2019) 134 (Supplement_1): 17.

https://doi.org/10.1182/blood-2019-122274

Published: 2019

Journal Articles

Prognostic Significance of IKZF1 , PAX5 , and CDKN2A Deletions in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Hyper-CVAD/MA with Dasatinib or Ponatinib

Yuya Sasaki, MD PhD, Nicholas J. Short, MD, Hagop M. Kantarjian, MD, Rebecca Garris, MSc, Nitin Jain, MD, Koji Sasaki, MD, Farhad Ravandi, MD, Marina Y Konopleva, MD PhD, Michael E. Rytting, MD, Guillermo Garcia-Manero, MD, Latasha Little, BS, Curtis Gumbs, Li Zhao, PhD, P. Andrew Futreal, PhD, Feng Wang, PhD, Koichi Takahashi, MD, Elias Jabbour, MD

Blood (2019) 134 (Supplement_1): 2753.

https://doi.org/10.1182/blood-2019-122017

Published: 2019

Journal Articles

Comprehensive Analysis of Genotype and Prior Exposures in Therapy-Related Myeloid Neoplasms (t-MNs)

Veronica A Guerra, MD, Yan Yuanqing, PhD, Joanne Hsu, BS, Feng Wang, PhD, Mansour Alfayez, MD, Kiyomi Morita, MD, Xingzhi Song, PhD, Courtney D. DiNardo, MD MSc, Marina Y Konopleva, MD PhD, Gautam M. Borthakur, MD, Guillermo Montalban Bravo, MD, Jianhua Zhang, PhD, Latasha Little, BS, Curtis Gumbs, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD, Andrew Futreal, PhD, Koichi Takahashi, MD

Blood (2019) 134 (Supplement_1): 458.

https://doi.org/10.1182/blood-2019-127498

Published: 2019

Journal Articles

Characterization of Changes in the T-Cell Receptor Repertoire in Patients with Acute Myeloid Leukemia with Durable Remission Following Allogeneic Stem Cell Transplant

Ronald M. Paranal, MD, Hagop M. Kantarjian, MD, Alexandre Reuben, PhD, Celine Kerros, PhD, Priya Koppikar, PhD, Latasha Little, BS, Curtis Gumbs, Nicholas J. Short, MD, Jorge E. Cortes, MD, Elias Jabbour, MD, Jeffrey J. Molldrem, P. Andrew Futreal, PhD, Ghayas C. Issa, MD

Blood (2019) 134 (Supplement_1): 5186.

https://doi.org/10.1182/blood-2019-129911

Published: 2019

Journal Articles

Pan-Myeloid Leukemia Analysis: Machine Learning-Based Approach to Predict Phenotype and Clinical Outcomes Using Mutation Data

Blood (2018) 132 (Supplement 1): 1801.

https://doi.org/10.1182/blood-2018-99-116685

Published: 2018

Journal Articles

Distinct Gene Expression Patterns of Minimal Residual Disease (MRD) Cells in High-Risk AML Patients Identified By RNA-Sequencing

Christopher B. Benton, MD, Ahmed Al Rawi, Feng Wang, PhD, Jianhua Zhang, PhD, Jeffrey L. Jorgensen, MD PhD, Hong Mu, MD PhD, Wendy Schober, Zoe Alaniz, Curtis Gumbs, Andy Futreal, PhD, Guillermo Garcia-Manero, MD, Hagop M. Kantarjian, MD, Nicholas Navin, PhD, Marina Y. Konopleva, MD PhD, Michael Andreeff, MD PhD

Blood (2018) 132 (Supplement 1): 2757.

https://doi.org/10.1182/blood-2018-99-120260

Published: 2018

Journal Articles

Single-Cell Atlas of Driver Mutations in Acute Myeloid Leukemia (AML)

Blood (2018) 132 (Supplement 1): 88.

https://doi.org/10.1182/blood-2018-99-117358

Published: 2018

Journal Articles

Clinical Heterogeneity of AML Is Associated with Mutational Heterogeneity

Blood (2018) 132 (Supplement 1): 5240.

https://doi.org/10.1182/blood-2018-99-117287

Published: 2018

Journal Articles

Comprehensive Genomic Analysis of IDH Inhibitor-Treated AML Samples Delineates Molecular Mechanisms of Differentiation and Heterogeneous Patterns of Acquired Resistance

Blood (2018) 132 (Supplement 1): 441.

https://doi.org/10.1182/blood-2018-99-116383

Published: 2018

Journal Articles

Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide

Blood (2018) 131 (16): 1820–1832.

https://doi.org/10.1182/blood-2017-11-817296

Published: 2018

Includes: Supplemental data

Journal Articles

Integrative Genomic Analysis of Adult Mixed Phenotype Acute Leukemia (MPAL)

Koichi Takahashi, MD, Feng Wang, PhD, Kiyomi Morita, MD, Yuanqing Yan, Keyur Patel, MD PhD, Carlos E. Bueso-Ramos, MD PhD, Curtis Gumbs, Jianhua Zhang, Steven Kornblau, MD, Courtney D. DiNardo, MDMSc, Farhad Ravandi, MBBS, Guillermo Garcia-Manero, MD, Elias J. Jabbour, MD, Michael Andreeff, MD PhD, Hagop M. Kantarjian, MD, Marina Konopleva, MD PhD, Andrew Futreal, PhD

Blood (2017) 130 (Supplement 1): 3904.

https://doi.org/10.1182/blood.V130.Suppl_1.3904.3904

Published: 2017

Journal Articles

Persistent Somatic Mutation at Remission Is Associated with Poor Survival and Higher Risk of Relapse in Patients with Acute Myeloid Leukemia

Blood (2017) 130 (Supplement 1): 2667.

https://doi.org/10.1182/blood.V130.Suppl_1.2667.2667

Published: 2017

Journal Articles

Clonal Hematopoiesis Increases Risk of Therapy-Related Myeloid Neoplasms

Koichi Takahashi, MD, Feng Wang, PhD, Hagop M. Kantarjian, MD, Doss Denaha, Kanhav Khann, MS, Keyur P. Patel, MD PhD, Sattva S. Neelapu, MD, Curtis Gumbs, Carlos E Bueso-Ramos, MD PhD, Courtney D. DiNardo, MD MSCE, Simona Colla, PhD, Farhad Ravandi, MD, Jianhua Zhang, Xifeng Wu, Felipe Samaniego, MD, Guillermo Garcia-Manero, MD, Andrew Futreal, PhD

Blood (2016) 128 (22): 38.

https://doi.org/10.1182/blood.V128.22.38.38

Published: 2016

Journal Articles

Clinico-Pathological Characteristics, Treatments and Outcomes of Patients with Dendritic Cell Sarcoma (DS)

Preetesh Jain, MBBS,MDDM,PhD, Keyur P. Patel, MD PhD, Andrew Futreal, PhD, Curtis Gumbs, Shimin Hu, PhD MD, Carlos Bueso Ramos, MD, Michael Wang, MD, Jorge Romaguera, Luis E. Fayad, MD, Robert Z. Orlowski, PhD, MD, Jeffrey Medeiros, Nathan Fowler, MD

Blood (2015) 126 (23): 2700.

https://doi.org/10.1182/blood.V126.23.2700.2700

Published: 2015

Journal Articles

IKZF3 p.L162R Is a Recurrent Hotspot Mutation in Chronic Lymphocytic Leukemia (CLL)

Koichi Takahashi, MD, Candida Vitale, MD, Carlos Bueso-Ramos, Feng Wang, PhD, Ekaterina Kim, MS, Jianhua Zhang, Curtis Gumbs, Mark Routbort, MD PhD, Zeev Estrov, MD, Nitin Jain, MD, Guillermo Garcia-Manero, MD, Hagop M. Kantarjian, MD, Jan A. Burger, MD PhD, Alessandra Ferrajoli, MD, Michael Keating, MBBS, Andrew Futreal, PhD, William Wierda, MD PhD

Blood (2015) 126 (23): 4136.

https://doi.org/10.1182/blood.V126.23.4136.4136

Published: 2015

Journal Articles

Presence of 4 or More Driver Mutations Predicts Poor Response to Hypomethylating Agent (HMA) Therapy and Poor Overall Survival in MDS

Koichi Takahashi, MD, Feng Wang, PhD, Seth Sahil, Jianhua Zhang, Curtis Gumbs, Ghayas C. Issa, MD, Christopher B. Benton, MD, Sherry Pierce, BSN, BA, Elias Jabbour, Naval Daver, MD, Tapan Kadia, MD, Courtney DiNardo, MD, Hagop M. Kantarjian, MD, Andrew Futreal, PhD, Guillermo Garcia-Manero, MD

Blood (2015) 126 (23): 1663.

https://doi.org/10.1182/blood.V126.23.1663.1663

Published: 2015

NARROW

Lenalidomide promotes the development of TP53 -mutated therapy-related myeloid neoplasms

Clonal dynamics and clinical implications of postremission clonal hematopoiesis in acute myeloid leukemia

Prognostic Significance of Genetic Alterations in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Hyper-CVAD Plus Dasatinib or Hyper-CVAD Plus Ponatinib

Clonal Dynamics and Clinical Implications of Post-Remission Clonal Hematopoiesis in Acute Myeloid Leukemia (AML)

Prognostic Significance of IKZF1 , PAX5 , and CDKN2A Deletions in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Hyper-CVAD/MA with Dasatinib or Ponatinib

Comprehensive Analysis of Genotype and Prior Exposures in Therapy-Related Myeloid Neoplasms (t-MNs)

Characterization of Changes in the T-Cell Receptor Repertoire in Patients with Acute Myeloid Leukemia with Durable Remission Following Allogeneic Stem Cell Transplant

Pan-Myeloid Leukemia Analysis: Machine Learning-Based Approach to Predict Phenotype and Clinical Outcomes Using Mutation Data

Distinct Gene Expression Patterns of Minimal Residual Disease (MRD) Cells in High-Risk AML Patients Identified By RNA-Sequencing

Single-Cell Atlas of Driver Mutations in Acute Myeloid Leukemia (AML)

Clinical Heterogeneity of AML Is Associated with Mutational Heterogeneity

Comprehensive Genomic Analysis of IDH Inhibitor-Treated AML Samples Delineates Molecular Mechanisms of Differentiation and Heterogeneous Patterns of Acquired Resistance

Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide

Integrative Genomic Analysis of Adult Mixed Phenotype Acute Leukemia (MPAL)

Persistent Somatic Mutation at Remission Is Associated with Poor Survival and Higher Risk of Relapse in Patients with Acute Myeloid Leukemia

Clonal Hematopoiesis Increases Risk of Therapy-Related Myeloid Neoplasms

Clinico-Pathological Characteristics, Treatments and Outcomes of Patients with Dendritic Cell Sarcoma (DS)

IKZF3 p.L162R Is a Recurrent Hotspot Mutation in Chronic Lymphocytic Leukemia (CLL)

Presence of 4 or More Driver Mutations Predicts Poor Response to Hypomethylating Agent (HMA) Therapy and Poor Overall Survival in MDS

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only